First Report of Compound Heterozygosity for Hb S (HBB : c.20A>T) and Hb Haringey (HBB: c.131A>G)
Sickle cell disease variants include hemoglobinopathies that result from inheritance of the sickle cell globin mutation with another globin mutation. The most common variants include the homozygous disease state (Hb SS disease), Hb S (HBB: c.20A>T)/Hb C (HBB: c.19G>A) disease and Hb S/β-thalassemia (Hb S/β-thal). Other rare/less common variants such as Hb S/Hb E (HBB: c.79G>A) and Hb S/HPFH [hereditary persistence of fetal hemoglobin (Hb)] disease exist. We report the first case of compound heterozygosity for Hb S and Hb Haringey (HBB: c.131A>G) in a 35-year-old male following a positive sickle screen test on hospital admission for pancreatitis. Ion exchange high performance liquid chromatography (HPLC), Hb electrophoresis and genetic sequencing were utilized to identify a new sickle Hb variant: Hb S/Hb Haringey. Hb S/Hb Haringey is a newly discovered sickle cell variant which seems to portray a mild/benign clinical phenotype of sickle cell disease.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Hemoglobin - 45(2021), 2 vom: 04. März, Seite 136-139 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ogu, Ugochi O [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9034-63-3 |
|---|
| Anmerkungen: |
Date Completed 28.02.2022 Date Revised 28.02.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/03630269.2021.1926276 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326821848 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326821848 | ||
| 003 | DE-627 | ||
| 005 | 20231225195427.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/03630269.2021.1926276 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1089.xml |
| 035 | |a (DE-627)NLM326821848 | ||
| 035 | |a (NLM)34134586 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ogu, Ugochi O |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a First Report of Compound Heterozygosity for Hb S (HBB |b c.20A>T) and Hb Haringey (HBB: c.131A>G) |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.02.2022 | ||
| 500 | |a Date Revised 28.02.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Sickle cell disease variants include hemoglobinopathies that result from inheritance of the sickle cell globin mutation with another globin mutation. The most common variants include the homozygous disease state (Hb SS disease), Hb S (HBB: c.20A>T)/Hb C (HBB: c.19G>A) disease and Hb S/β-thalassemia (Hb S/β-thal). Other rare/less common variants such as Hb S/Hb E (HBB: c.79G>A) and Hb S/HPFH [hereditary persistence of fetal hemoglobin (Hb)] disease exist. We report the first case of compound heterozygosity for Hb S and Hb Haringey (HBB: c.131A>G) in a 35-year-old male following a positive sickle screen test on hospital admission for pancreatitis. Ion exchange high performance liquid chromatography (HPLC), Hb electrophoresis and genetic sequencing were utilized to identify a new sickle Hb variant: Hb S/Hb Haringey. Hb S/Hb Haringey is a newly discovered sickle cell variant which seems to portray a mild/benign clinical phenotype of sickle cell disease | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Compound heterozygosity | |
| 650 | 4 | |a Hb Haringey | |
| 650 | 4 | |a Hb S/Hb Haringey | |
| 650 | 4 | |a sickle cell disease | |
| 650 | 7 | |a Hemoglobin, Sickle |2 NLM | |
| 650 | 7 | |a Fetal Hemoglobin |2 NLM | |
| 650 | 7 | |a 9034-63-3 |2 NLM | |
| 700 | 1 | |a Reyes Gil, Morayma |e verfasserin |4 aut | |
| 700 | 1 | |a Tolu, Seda S |e verfasserin |4 aut | |
| 700 | 1 | |a Acharya, Seetharama A |e verfasserin |4 aut | |
| 700 | 1 | |a Minniti, Caterina P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hemoglobin |d 1993 |g 45(2021), 2 vom: 04. März, Seite 136-139 |w (DE-627)NLM000202541 |x 1532-432X |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2021 |g number:2 |g day:04 |g month:03 |g pages:136-139 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/03630269.2021.1926276 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2021 |e 2 |b 04 |c 03 |h 136-139 | ||